JWH-073 (original) (raw)
JWH-073 – organiczny związek chemiczny, syntetyczny kanabinoid otrzymany przez Johna W. Huffmana (stąd akronim JWH). W Polsce od 2010 roku jest w grupie I-N Ustawy o przeciwdziałaniu narkomanii.
| Property | Value |
|---|---|
| dbo:abstract | JWH-073 ist eine synthetische chemische Verbindung aus der Gruppe der Alkylindol-Derivate und wurde von John W. Huffman entwickelt. Es wirkt als Partialagonist am CB1 und mit etwa 5-fach höherer Selektivität am CB2-Rezeptor. Es zeigt unter anderem analgetische Eigenschaften. Dieses Cannabinoid wurde als zugesetzter Wirkstoff in Produkten gefunden, die von den Herstellern als „Kräutermischungen“ etwa unter der Bezeichnung „Spice“ oder in ähnlichen Produkten vertrieben wurden. JWH-073 hat nach Auffassung des Sachverständigenausschusses für Betäubungsmittel in Deutschland eine stärkere Wirkung als THC. (de) JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound. On 20 April 2009, JWH-073 was claimed by researchers at the University of Freiburg to have been found in a "fertiliser" product called "Forest Humus", along with another synthetic cannabinoid (C8)-CP 47,497. These claims were confirmed in July 2009 when tests of Spice product, seized after the legal ban on JWH-018 had gone into effect in Germany, were shown to contain the unregulated compound JWH-073 instead. The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well established in treatment of neuropathic pain, as well as cancer pain and arthritis. These compounds work by mimicking the body's naturally-produced endocannabinoid hormones such as 2-arachidonoylglycerol and anandamide, which are biologically active and can exacerbate or inhibit nerve signaling. As the cause is poorly understood in chronic pain states, more research and development must be done before we can realize the therapeutic potential of this class of biologic compounds. (en) JWH-073 – organiczny związek chemiczny, syntetyczny kanabinoid otrzymany przez Johna W. Huffmana (stąd akronim JWH). W Polsce od 2010 roku jest w grupie I-N Ustawy o przeciwdziałaniu narkomanii. (pl) |
| dbo:casNumber | 208987-48-8 |
| dbo:fdaUniiCode | BBX3BP2772 |
| dbo:pubchem | 10471670 |
| dbo:thumbnail | wiki-commons:Special:FilePath/JWH073.svg?width=300 |
| dbo:wikiPageID | 16564159 (xsd:integer) |
| dbo:wikiPageLength | 10246 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1060041294 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:John_W._Huffman dbr:University_of_Freiburg dbr:Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons dbc:Designer_drugs dbr:Controlled_Substances_Act dbc:JWH_cannabinoids dbr:2-arachidonoylglycerol dbc:Naphthoylindoles dbr:CP_47,497 dbr:Analgesic dbr:Anandamide dbr:Drug_Enforcement_Administration dbr:Food_and_Drug_Administration_Safety_and_Innovation_Act dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists dbr:HU-210 dbr:JWH-018 dbr:JWH-019 dbr:JWH-081 dbr:Tetrahydrocannabinol dbr:Synthetic_cannabinoid dbr:Naphthoylindole dbr:Cannabinoid dbr:Spice_(drug) dbr:MEPIRAPIM dbr:File:4'-methyl-JWH-073_structure.png dbr:File:Jwh-073.JPG |
| dbp:c | 23 (xsd:integer) |
| dbp:casNumber | 208987 (xsd:integer) |
| dbp:chemspiderid | 8647081 (xsd:integer) |
| dbp:h | 21 (xsd:integer) |
| dbp:iupacName | Naphthalen-1-yl-methanone (en) |
| dbp:legalCa | Schedule II (en) |
| dbp:legalDe | Anlage II (en) |
| dbp:legalStatus | Illegal in Latvia & Poland (en) |
| dbp:legalUk | Class B (en) |
| dbp:legalUs | Schedule I (en) |
| dbp:n | 1 (xsd:integer) |
| dbp:o | 1 (xsd:integer) |
| dbp:pubchem | 10471670 (xsd:integer) |
| dbp:smiles | CCCCN1C=CCC3=CC=CC4=CC=CC=C43 (en) |
| dbp:stdinchi | 1 (xsd:integer) |
| dbp:stdinchikey | VCHHHSMPMLNVGS-UHFFFAOYSA-N (en) |
| dbp:unii | BBX3BP2772 (en) |
| dbp:verifiedfields | changed (en) |
| dbp:verifiedrevid | 451057329 (xsd:integer) |
| dbp:watchedfields | changed (en) |
| dbp:wikiPageUsesTemplate | dbt:Cannabinoidergics dbt:Cannabinoids dbt:Clear-left dbt:Drugbox dbt:Hallucinogens dbt:Reflist dbt:See_also dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite |
| dct:subject | dbc:Designer_drugs dbc:JWH_cannabinoids dbc:Naphthoylindoles dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists |
| gold:hypernym | dbr:Chemical |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAromaticKetones yago:WikicatNaphthalenes yago:Abbreviation107091587 yago:Abstraction100002137 yago:Chemical114806838 yago:Compound114818238 yago:Form106290637 yago:Hydrocarbon114911057 yago:Ketone114926294 yago:LanguageUnit106284225 yago:Material114580897 yago:Matter100020827 yago:Naphthalene114958564 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 yago:WikicatKetones yago:Word106286395 dbo:ChemicalCompound dbo:Drug yago:Substance100019613 yago:WikicatAbbreviations umbel-rc:DrugProduct |
| rdfs:comment | JWH-073 – organiczny związek chemiczny, syntetyczny kanabinoid otrzymany przez Johna W. Huffmana (stąd akronim JWH). W Polsce od 2010 roku jest w grupie I-N Ustawy o przeciwdziałaniu narkomanii. (pl) JWH-073 ist eine synthetische chemische Verbindung aus der Gruppe der Alkylindol-Derivate und wurde von John W. Huffman entwickelt. Es wirkt als Partialagonist am CB1 und mit etwa 5-fach höherer Selektivität am CB2-Rezeptor. Es zeigt unter anderem analgetische Eigenschaften. (de) JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound. The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well established in treatment of neuropathic pain, as well as cancer pain and arthritis. (en) |
| rdfs:label | JWH-073 (de) JWH-073 (en) JWH-073 (pl) |
| rdfs:seeAlso | dbr:JWH-018 |
| owl:sameAs | freebase:JWH-073 yago-res:JWH-073 wikidata:JWH-073 dbpedia-de:JWH-073 dbpedia-fi:JWH-073 dbpedia-hr:JWH-073 dbpedia-pl:JWH-073 dbpedia-sh:JWH-073 dbpedia-sr:JWH-073 https://global.dbpedia.org/id/3vScK |
| prov:wasDerivedFrom | wikipedia-en:JWH-073?oldid=1060041294&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/4'-methyl-JWH-073_structure.png wiki-commons:Special:FilePath/JWH073.svg wiki-commons:Special:FilePath/Jwh-073.jpg |
| foaf:isPrimaryTopicOf | wikipedia-en:JWH-073 |
| is dbo:wikiPageWikiLink of | dbr:List_of_designer_drugs dbr:Mepirapim dbr:Liebermann_reagent dbr:List_of_psychedelic_drugs dbr:Synthetic_cannabinoids dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:List_of_JWH_cannabinoids dbr:List_of_Schedule_I_drugs_(US) dbr:JWH-007 dbr:JWH-018 dbr:JWH-019 dbr:JWH-047 dbr:JWH-048 dbr:JWH-057 dbr:JWH-200 dbr:JWH-250 dbr:C23H21NO dbr:Cannabinoid dbr:Cannabinoid_receptor_type_1 dbr:Temporary_class_drug |
| is foaf:primaryTopic of | wikipedia-en:JWH-073 |
